<VariationArchive RecordType="classified" VariationID="6288" VariationName="NM_002335.4(LRP5):c.4119dup (p.Lys1374fs)" VariationType="Duplication" Accession="VCV000006288" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-18" DateCreated="2018-02-25" MostRecentSubmission="2018-02-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21327" VariationID="6288">
      <GeneList>
        <Gene Symbol="LRP5" FullName="LDL receptor related protein 5" GeneID="4041" HGNC_ID="HGNC:6697" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="68298412" stop="68449275" display_start="68298412" display_stop="68449275" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="68080107" stop="68216742" display_start="68080107" display_stop="68216742" Strand="+" />
          </Location>
          <OMIM>603506</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LRP5">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LRP5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002335.4(LRP5):c.4119dup (p.Lys1374fs)</Name>
      <CanonicalSPDI>NC_000011.10:68438451:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="68438451" stop="68438452" display_start="68438451" display_stop="68438452" variantLength="1" positionVCF="68438451" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="68205919" stop="68205920" display_start="68205919" display_stop="68205920" variantLength="1" positionVCF="68205919" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>K793fs</ProteinChange>
      <ProteinChange>K1374fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.68438453dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.68438453dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.68205921dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.68205921dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015835.2" sequenceAccession="NG_015835" sequenceVersion="2" change="g.130814dup">
            <Expression>NG_015835.2:g.130814dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291902.2" sequenceAccession="NM_001291902" sequenceVersion="2" change="c.2376dup">
            <Expression>NM_001291902.2:c.2376dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278831.1" sequenceAccession="NP_001278831" sequenceVersion="1" change="p.Lys793fs">
            <Expression>NP_001278831.1:p.Lys793fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002335.4" sequenceAccession="NM_002335" sequenceVersion="4" change="c.4119dup" MANESelect="true">
            <Expression>NM_002335.4:c.4119dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002326.2" sequenceAccession="NP_002326" sequenceVersion="2" change="p.Lys1374fs">
            <Expression>NP_002326.2:p.Lys1374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA118102" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603506.0021" DB="OMIM" />
        <XRef Type="rs" ID="80358321" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002335.4(LRP5):c.4119dup (p.Lys1374fs) AND Exudative vitreoretinopathy 4, autosomal dominant" Accession="RCV000006668" Version="3">
        <ClassifiedConditionList TraitSetID="1745">
          <ClassifiedCondition DB="MedGen" ID="C4016838">Exudative vitreoretinopathy 4, autosomal dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-02-25" MostRecentSubmission="2018-02-25">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15024691</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1745" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10231" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Exudative vitreoretinopathy 4, autosomal dominant</ElementValue>
              </Name>
              <XRef ID="C4016838" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26851" SubmissionDate="2018-02-22" DateLastUpdated="2018-02-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603506.0021_EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT" title="LRP5, 1-BP INS, 4119C_EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT" />
        <ClinVarAccession Accession="SCV000026851" DateUpdated="2018-02-25" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of an American family with autosomal dominant exudative vitreoretinopathy (EVR4; 601813), Toomes et al. (2004) identified a heterozygous 1-bp insertion in exon 20 of the LRP5 gene, 4119insC, resulting in a frameshift at codon 1374 with a premature stop codon following 175 incorrect amino acids. Two asymptomatic members carried the mutation but had not been examined by fluorescein angiography to exclude a very mild phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">15024691</ID>
              </Citation>
              <XRef DB="OMIM" ID="601813" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LRP5" />
          </GeneList>
          <Name>LRP5, 1-BP INS, 4119C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 4119C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603506.0021" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26851" TraitType="Disease" MappingType="Name" MappingValue="EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT" MappingRef="Preferred">
        <MedGen CUI="C4016838" Name="Exudative vitreoretinopathy 4, autosomal dominant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

